| P50 | author | Alan Fairlamb | Q4706598 |
| | Jörg Feldmann | Q54652880 |
| | Susan Wyllie | Q56545158 |
| | Andrea Raab | Q90783627 |
| | Meghan Rose Perry | Q101062179 |
| P2860 | cites work | Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome? | Q56558896 |
| | Intracellular survival of Staphylococcus aureus due to alteration of cellular activity in arsenic and lead intoxicated mature Swiss albino mice | Q78726954 |
| | The anti-trypanosome drug fexinidazole shows potential for treating visceral leishmaniasis | Q24633734 |
| | Arsenic groundwater contamination in Middle Ganga Plain, Bihar, India: a future danger? | Q24815356 |
| | Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects. | Q24815894 |
| | Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004 | Q28283745 |
| | Sodium stibogluconate (Pentostam) potentiates oxidant production in murine visceral leishmaniasis and in human blood | Q28344600 |
| | Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden | Q28476400 |
| | Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? | Q29038941 |
| | Drug resistance in leishmaniasis | Q29616242 |
| | Dose translation from animal to human studies revisited | Q29618049 |
| | Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent? | Q34043521 |
| | Role of metabolism in arsenic toxicity | Q34085794 |
| | Did medicated salt hasten the spread of chloroquine resistance in Plasmodium falciparum? | Q34355300 |
| | Management of visceral leishmaniasis in rural primary health care services in Bihar, India | Q34443655 |
| | Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda | Q34768663 |
| | Impact of life stage and duration of exposure on arsenic-induced proliferative lesions and neoplasia in C3H mice | Q36393258 |
| | Visceral leishmaniasis (kala-azar): challenges ahead | Q36508336 |
| | Molecular mechanisms of antimony resistance in Leishmania | Q36716130 |
| | Arsenic-induced carcinogenesis--oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment | Q37662780 |
| | Visceral leishmaniasis: elimination with existing interventions | Q37859955 |
| | Leishmania antimony resistance: what we know what we can learn from the field. | Q37907925 |
| | Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru. | Q39185984 |
| | In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent | Q39444290 |
| | American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility? | Q39614525 |
| | Clinical risk factors for therapeutic failure in kala-azar patients treated with pentavalent antimonials in Nepal | Q40380970 |
| | New mechanisms of drug resistance in parasitic protozoa | Q40945183 |
| | Novel mechanism of drug resistance in kala azar field isolates | Q42605042 |
| | Food intake, water intake, and drinking spout side preference of 28 mouse strains | Q43237768 |
| | Greatly enhanced arsenic shoot assimilation in rice leads to elevated grain levels compared to wheat and barley | Q46223842 |
| | Effect of chronic intake of arsenic-contaminated water on liver | Q46556903 |
| | Analysis of T-cell proliferation and cytokine secretion in the individuals exposed to arsenic | Q47390074 |
| | Refinement of techniques for the propagation of Leishmania donovani in hamsters. | Q51810404 |
| | Assessment of lymphocyte subpopulations and cytokine secretion in children exposed to arsenic. | Q53349595 |
| | Leishmaniasis | Q54152502 |
| | High level arsenite resistance in Leishmania tarentolae is mediated by an active extrusion system. | Q54196331 |
| P433 | issue | 49 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | arsenic | Q871 |
| | drinking water | Q7892 |
| | visceral leishmaniasis | Q2046113 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 19932-19937 | |
| P577 | publication date | 2013-10-28 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Chronic exposure to arsenic in drinking water can lead to resistance to antimonial drugs in a mouse model of visceral leishmaniasis | |
| P478 | volume | 110 | |